Flexion Therapeutics, Inc. (FLXN) News
Filter FLXN News Items
FLXN News Results
|Loading, please wait...|
FLXN News Highlights
- 500 - Internal server error
- Over the past 18 days, the trend for FLXN's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about FLXN are MD.
Latest FLXN News From Around the Web
Below are the latest news stories about Flexion Therapeutics Inc that investors may wish to consider to help them evaluate FLXN as an investment opportunity.
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade. Most investors who decided to stick with hedge funds after a rough 2018 recouped their losses by the end of the fourth quarter of 2019. A significant number of hedge funds continued their strong […]
BURLINGTON, Mass., July 29, 2021 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it will report its second-quarter 2021 financial results after the close of the U.S. financial markets on Wednesday, August 4, 2021 at 4:30 p.m. ET. A live webcast of the conference call can be accessed through the “Investors” tab on the Flexion Therapeutics website, and a replay will be available online after the call. For those planning to ask a question, the dial-in number for th
Flexion Therapeutics (FLXN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BURLINGTON, Mass., July 12, 2021 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced the appointment of Utpal Koppikar, Chief Financial Officer of Atara Biotherapeutics, to its Board of Directors. Mr. Koppikar will serve as the chair of Flexion’s audit committee. "I am thrilled to welcome Utpal to Flexion’s Board, as his extensive financial experience leading biotechnology companies makes him an outstanding addition to our Board of Directors,” said Michael Clayman, MD, P
BURLINGTON, Mass., July 02, 2021 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced equity inducement grants to five new employees consisting of 20,440 restricted stock units. The Compensation Committee of the Board of Directors approved the grants with an effective date of July 1, 2021. The restricted stock units were granted as inducements material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
Carnival Corporation & plc (NYSE/LSE: CCL; NYSE: CUK), the world's largest cruise company, today announced its initial set of 2030 sustainability goals, as part of the company's ongoing commitment to sustainability and compliance throughout its global operations.
P&O Cruises has announced its expected deployment and phased re-start plan for the remainder of 2021 and into early 2022.
Holland America Line Announces Fall Cruise 2021 Plans with Two Ships Operating West Coast Departures from San Diego and Four Ships Sailing in the Caribbean from Fort Lauderdale
Holland America Line is gearing up to restart cruising out of Port of San Diego in California beginning with a season of cruises to Mexico, Hawaii and along the California coast aboard Koningsdam and Zuiderdam. The cruise line has expanded the season with the addition of six new cruise departures for Zuiderdam and two new cruises on Koningsdam, offering a total of 40 cruises from San Diego from September 2021 through April 2022.
Carnival Cruise Line Partners With Guy Fieri's Flavortown Kitchen For New Home Delivery Of Guy's Burger Joint Offerings
Fans of Guy's Burger Joint on Carnival Cruise Line can now satisfy their cravings off the ship with delivery of the chef's hand-crafted "Straight Up" burger for a limited time only.
Flexion Therapeutics, Inc.'s (NASDAQ:FLXN) CEO Compensation Is Looking A Bit Stretched At The Moment
The underwhelming share price performance of Flexion Therapeutics, Inc. ( NASDAQ:FLXN ) in the past three years would...